BIS(MALTOLATO)OXOVANADIUM

O=[V++].CC1=C([O-])C(=O)C=CO1.CC2=C([O-])C(=O)C=CO2

InChIKey=XUOLEICXAPEOSI-UHFFFAOYSA-L

InChI=1S/2C6H6O3.O.V/c2*1-4-6(8)5(7)2-3-9-4;;/h2*2-3,8H,1H3;;/q;;;+2/p-2

Targets

Primary Target	Pharmacology	Condition	Potency
Tyrosine-protein phosphatase non-receptor type 1 4 Target ID: P18031 Gene ID: 5770.0 Gene Symbol: PTPN1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/18728000 \| https://www.ncbi.nlm.nih.gov/pubmed/12888267	Inhibitor 8504		0.86 µM [IC50]

PubMed

Title	Date	PubMed
Exposure to bis(maltolato)oxovanadium(IV) increases levels of hepcidin mRNA and impairs the homeostasis of iron but not that of manganese.	2014-11	25168077
Effect of bis (maltolato) oxovanadium (BMOV) in uric acid and sodium arsenite-induced vascular endothelial dysfunction in rats.	2008-08-29	17658639
Effects of bis(alpha-furancarboxylato)oxovanadium(IV) on glucose metabolism in fat-fed/streptozotocin-diabetic rats.	2007-10-31	17651728
Vanadate, an inhibitor of stromelysin and collagenase expression, suppresses collagen induced arthritis.	2007-09	17696279
Mechanisms by which bis(maltolato)oxovanadium(IV) normalizes phosphoenolpyruvate carboxykinase and glucose-6-phosphatase expression in streptozotocin-diabetic rats in vivo.	2002-12	12446591
Vanadium increases GLUT4 in diabetic rat skeletal muscle.	2002-04	12083368
Bis(maltolato)oxovanadium(IV) inhibits the activity of PTP1B in Zucker rat skeletal muscle in vivo.	2002-01	11936837
Effect of vanadium on insulin sensitivity and appetite.	2001-06	11398143

Name

Type

Language

BIS(MALTOLATO)OXOVANADIUM

Common Name

English

BMOV

Preferred Name

English

VO(MA)2

Common Name

English

BIS((2-METHYL-4-OXO-PYRAN-3-YL)OXY)-OXO-VANADIUM

Systematic Name

English

VANADIUM, BIS(3-HYDROXY-2-METHYL-4H-PYRAN-4-ONATO-O3,O4)OXO-, (SP-5-31)-

Systematic Name

English

Code System Code Type Description

EPA CompTox

DTXSID50191593